107 related articles for article (PubMed ID: 6821550)
1. Iron and deferoxamine in lymphocyte blastogenesis.
Lipsky JJ; Lietman PS
J Immunopharmacol; 1980; 2(2):179-87. PubMed ID: 6821550
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Kuvibidila SR; Porretta C
J Cell Biochem; 2002; 86(3):571-82. PubMed ID: 12210763
[TBL] [Abstract][Full Text] [Related]
3. Impairment of blastogenic response of splenic lymphocytes from iron-deficient mice. In vitro repletion by hemin, transferrin, and ferric chloride.
Kuvibidila SR; Nauss KM; Baliga SB; Suskind RM
Am J Clin Nutr; 1983 Apr; 37(4):557-65. PubMed ID: 6601454
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.
Lederman HM; Cohen A; Lee JW; Freedman MH; Gelfand EW
Blood; 1984 Sep; 64(3):748-53. PubMed ID: 6380622
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
Kuvibidila SR; Kitchens D; Baliga BS
J Cell Biochem; 1999 Sep; 74(3):468-78. PubMed ID: 10412047
[TBL] [Abstract][Full Text] [Related]
6. Effect of an iron-chelating agent on lymphocyte proliferation.
Bowern N; Ramshaw IA; Badenoch-Jones P; Doherty PC
Aust J Exp Biol Med Sci; 1984 Dec; 62 ( Pt 6)():743-54. PubMed ID: 6241825
[TBL] [Abstract][Full Text] [Related]
7. Iron, desferrioxamine, and ATP interactions in proliferating lymphocytes and B-cell lines.
Latunde-Dada GO; Young SP
Biochem Soc Trans; 1995 May; 23(2):213S. PubMed ID: 7672233
[No Abstract] [Full Text] [Related]
8. Role of iron-ATP complex in lymphocyte proliferation and infiltration.
Anghileri LJ; Ortal EM; Thouvenot P
Biol Trace Elem Res; 2005; 108(1-3):69-75. PubMed ID: 16327061
[TBL] [Abstract][Full Text] [Related]
9. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine.
Thorson JA; Smith KM; Gomez F; Naumann PW; Kemp JD
Cell Immunol; 1991 Apr; 134(1):126-37. PubMed ID: 1826464
[TBL] [Abstract][Full Text] [Related]
10. Impairment of blastogenic response of splenic lymphocytes from iron-deficient mice: in vivo repletion.
Kuvibidila S; Nauss KM; Baliga BS; Suskind RM
Am J Clin Nutr; 1983 Jan; 37(1):15-25. PubMed ID: 6600368
[TBL] [Abstract][Full Text] [Related]
11. The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro.
Soyano A; Chinea M; Romano EL
Immunopharmacology; 1984 Dec; 8(3-4):163-9. PubMed ID: 6519962
[TBL] [Abstract][Full Text] [Related]
12. Proceedings: Effect of iron deficiency on DNA synthesis.
Hoffbrand AV; Ganeshaguru K; Tattersall MH; Tripp E
Clin Sci Mol Med; 1974 Feb; 46(2):12P. PubMed ID: 4817251
[No Abstract] [Full Text] [Related]
13. Iron deficiency and in vitro iron chelation reduce the expression of cluster of differentiation molecule (CD)28 but not CD3 receptors on murine thymocytes and spleen cells.
Kuvibidila SR; Porretta C
Br J Nutr; 2003 Jul; 90(1):179-89. PubMed ID: 12844390
[TBL] [Abstract][Full Text] [Related]
14. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylcholanthrene and benzanthracene on blastogenesis and aryl hydrocarbon hydroxylase induction in splenic lymphocytes from three inbred strains of mice.
Alfred LJ; Wojdani A
Int J Immunopharmacol; 1983; 5(2):123-9. PubMed ID: 6874165
[TBL] [Abstract][Full Text] [Related]
16. Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling.
Zhang J; Hu W; Ding C; Yao G; Zhao H; Wu S
Toxicol Lett; 2019 Oct; 313():50-59. PubMed ID: 31238089
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine.
Breidbach T; Scory S; Krauth-Siegel RL; Steverding D
Int J Parasitol; 2002 Apr; 32(4):473-9. PubMed ID: 11849643
[TBL] [Abstract][Full Text] [Related]
18. Non-transferrin dependent 59Fe uptake in phytohemagglutinin-stimulated human peripheral lymphocytes.
Hamazaki S; Glass J
Exp Hematol; 1992 May; 20(4):436-41. PubMed ID: 1568461
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte activation, iron uptake and release by human mononuclear leukocytes in the presence of desferrioxamine.
Taylor PG; Soyano A; Romano E; Layrisse M
Immunopharmacol Immunotoxicol; 1988; 10(2):165-78. PubMed ID: 3171105
[TBL] [Abstract][Full Text] [Related]
20. Deferoxamine inhibits microglial activation, attenuates blood-brain barrier disruption, rescues dendritic damage, and improves spatial memory in a mouse model of microhemorrhages.
He XF; Lan Y; Zhang Q; Liu DX; Wang Q; Liang FY; Zeng JS; Xu GQ; Pei Z
J Neurochem; 2016 Aug; 138(3):436-47. PubMed ID: 27167158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
